Patents by Inventor Nicole van der Weerden

Nicole van der Weerden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10568930
    Abstract: Agents and formulations and cells including plant extracts are useful in a method for controlling pathogen infestation in human and animal subjects. A method for inhibiting growth or infestation of a pathogen in or on a human or animal subject, includes contacting the pathogen with an effective amount of a combination of a plant defensin or a functional natural or synthetic derivative or variant thereof and either: (i) a proteinase inhibitor; or (ii) a chemical pathogenicidic or pathogenostatic agent; in a combined amount effective to inhibit growth or infestation of the pathogen.
    Type: Grant
    Filed: April 24, 2015
    Date of Patent: February 25, 2020
    Assignee: Hexima Limited
    Inventors: Nicole Van Der Weerden, Marilyn Anne Anderson, Jennifer Payne
  • Publication number: 20190327965
    Abstract: Pathogen infection and infestation can be controlled in humans, animals and plants by contacting the pathogen with an effective amount of a combination of a plant defensin or a functional natural or synthetic derivative or variant thereof and a non-defensin peptide. Pathogen contamination in environmental locales can also be controlled. The combination of the defensin and peptide are synergistic compared to the use of each alone at the same individual dose as used in the combination. The combinations can be presented in agents and natural and synthetic formulations and extracts.
    Type: Application
    Filed: March 18, 2019
    Publication date: October 31, 2019
    Inventors: Nicole VAN DER WEERDEN, Marilyn Anne ANDERSON
  • Patent number: 10357536
    Abstract: The protection of plants and human and non-human subjects from pathogens enables a multivalent approach to inhibiting pathogen infection in plant and human and non-human animal subjects and to ameliorate damage to susceptible subjects. A method for protecting a subject from a disease associated with infection by a pathogen includes providing cells of said subject with a Class I defensin and a permeabilizing defensin or a precursor or a functional homolog, analog, derivative or variant thereof of either or both.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: July 23, 2019
    Assignee: Hexima Limited
    Inventors: Nicole Van Der Weerden, Marilyn Anne Anderson
  • Patent number: 10231450
    Abstract: Agents and natural and synthetic formulations and extracts are useful in control of pathogen infection and infestation in humans, animals and plants, as well as pathogen contamination in environmental locales. A method inhibits growth or infection or infestation of a pathogen, including contacting the pathogen with an effective amount of a combination of a plant defensin or a functional natural or synthetic derivative or variant thereof and a non-defensin peptide, such as a cathelicidin peptide, a hairpin peptide, a hairpin peptide from which disulfide bridges have been removed, indolicidin, synthetic peptide CP-29, or a peptide derived from a cystatin. The combination of the defensin and peptide are synergistic compared to the use of each alone at the same individual dose as used in the combination.
    Type: Grant
    Filed: April 23, 2015
    Date of Patent: March 19, 2019
    Assignee: Hexima Limited
    Inventors: Nicole Van Der Weerden, Marilyn Anne Anderson
  • Patent number: 10174339
    Abstract: This disclosure relates generally to the field of anti-pathogenic agents, including a modified defensin molecule with anti-pathogen activity. Genetically modified plants and their progeny or parts expressing or containing the modified defensin and anti-pathogen compositions for use in horticulture and agriculture and as animal and human medicaments are also provided.
    Type: Grant
    Filed: October 18, 2016
    Date of Patent: January 8, 2019
    Assignee: Hexima Limited
    Inventors: Nicole Van Der Weerden, Marilyn Anne Anderson
  • Publication number: 20180214512
    Abstract: The protection of plants and human and non-human subjects from pathogens enables a multivalent approach to inhibiting pathogen infection in plant and human and non-human animal subjects and to ameliorate damage to susceptible subjects. A method for protecting a subject from a disease associated with infection by a pathogen includes providing cells of said subject with a Class I defensin and a permeabilizing defensin or a precursor or a functional homolog, analog, derivative or variant thereof of either or both.
    Type: Application
    Filed: March 23, 2018
    Publication date: August 2, 2018
    Inventors: Nicole VAN DER WEERDEN, Marilyn Anne ANDERSON
  • Patent number: 9943564
    Abstract: The present disclosure teaches the protection of plants and human and non-human subjects from pathogens. The present disclosure enables a multivalent approach to inhibiting pathogen infection in plant and human and non-human animal subjects and to ameliorate damage to susceptible subjects.
    Type: Grant
    Filed: November 22, 2013
    Date of Patent: April 17, 2018
    Assignee: Hexima Limited
    Inventors: Nicole Van Der Weerden, Marilyn Anne Anderson
  • Patent number: 9848603
    Abstract: A system for reducing the incidence or severity of fungal infection of a plant, comprising a chemical fungicide component, which may be provided by foliar or root (soil or liquid nutrient) application, together with an antifungal plant defensin not in nature expressed in the plant being protected or expressed in lower amounts or in different tissues, provides synergistic improvement in protection against infection by a plant pathogenic fungus which is susceptible to the defensin and the fungicide. The fungicide can be a strobilurin or a triazole, and the defensin can be selected from a wide range of known defensins, for example, NaD1 and others, or it can be a chimeric defensin engineered for low toxicity to the plant. The defensin can be provided as a protein formulation, optionally together with the fungicide, or it can be provided by recombinant expression in the plant to be protected from fungal infection.
    Type: Grant
    Filed: May 12, 2015
    Date of Patent: December 26, 2017
    Assignee: Hexima Limited
    Inventors: Marilyn Anderson, Robyn Heath, James McKenna, Nicole Van Der Weerden
  • Publication number: 20170049102
    Abstract: Agents and natural and synthetic formulations and extracts are useful in control of pathogen infection and infestation in humans, animals and plants, as well as pathogen contamination in environmental locales. A method inhibits growth or infection or infestation of a pathogen, including contacting the pathogen with an effective amount of a combination of a plant defensin or a functional natural or synthetic derivative or variant thereof and a non-defensin peptide, such as a cathelicidin peptide, a hairpin peptide, a hairpin peptide from which disulfide bridges have been removed, indolicidin, synthetic peptide CP-29, or a peptide derived from a cystatin. The combination of the defensin and peptide are synergistic compared to the use of each alone at the same individual dose as used in the combination.
    Type: Application
    Filed: April 23, 2015
    Publication date: February 23, 2017
    Inventors: Nicole VAN DER WEERDEN, Marilyn Anne ANDERSON
  • Publication number: 20170042966
    Abstract: Agents and formulations and cells including plant extracts are useful in a method for controlling pathogen infestation in human and animal subjects. A method for inhibiting growth or infestation of a pathogen in or on a human or animal subject, includes contacting the pathogen with an effective amount of a combination of a plant defensin or a functional natural or synthetic derivative or variant thereof and either: (i) a proteinase inhibitor; or (ii) a chemical pathogenicidic or pathogenostatic agent; in a combined amount effective to inhibit growth or infestation of the pathogen.
    Type: Application
    Filed: April 24, 2015
    Publication date: February 16, 2017
    Inventors: Nicole VAN DER WEERDEN, Marilyn Anne ANDERSON, Jennifer PAYNE
  • Publication number: 20170029842
    Abstract: This disclosure relates generally to the field of anti-pathogenic agents, including a modified defensin molecule with anti-pathogen activity. Genetically modified plants and their progeny or parts expressing or containing the modified defensin and anti-pathogen compositions for use in horticulture and agriculture and as animal and human medicaments are also provided.
    Type: Application
    Filed: October 18, 2016
    Publication date: February 2, 2017
    Inventors: Nicole VAN DER WEERDEN, Marilyn Anne ANDERSON
  • Patent number: 9497908
    Abstract: This disclosure relates generally to the field of anti-pathogenic agents, including a modified defensin molecule with anti-pathogen activity. Genetically modified plants and their progeny or parts expressing or containing the modified defensin and anti-pathogen compositions for use in horticulture and agriculture and as animal and human medicaments are also provided.
    Type: Grant
    Filed: February 7, 2012
    Date of Patent: November 22, 2016
    Assignee: HEXIMA LIMITED
    Inventors: Nicole Van Der Weerden, Marilyn Anne Anderson
  • Publication number: 20150283204
    Abstract: The present disclosure teaches the protection of plants and human and non-human subjects from pathogens. The present disclosure enables a multivalent approach to inhibiting pathogen infection in plant and human and non-human animal subjects and to ameliorate damage to susceptible subjects.
    Type: Application
    Filed: November 22, 2013
    Publication date: October 8, 2015
    Applicant: Hexima Limited
    Inventors: Nicole Van Der Weerden, Marilyn Anne Anderson
  • Publication number: 20150237860
    Abstract: A system for reducing the incidence or severity of fungal infection of a plant, comprising a chemical fungicide component, which may be provided by foliar or root (soil or liquid nutrient) application, together with an antifungal plant defensin not in nature expressed in the plant being protected or expressed in lower amounts or in different tissues, provides synergistic improvement in protection against infection by a plant pathogenic fungus which is susceptible to the defensin and the fungicide. The fungicide can be a strobilurin or a triazole, and the defensin can be selected from a wide range of known defensins, for example, NaD1 and others, or it can be a chimeric defensin engineered for low toxicity to the plant. The defensin can be provided as a protein formulation, optionally together with the fungicide, or it can be provided by recombinant expression in the plant to be protected from fungal infection.
    Type: Application
    Filed: May 12, 2015
    Publication date: August 27, 2015
    Inventors: Marilyn ANDERSON, Robyn HEATH, James MCKENNA, Nicole VAN DER WEERDEN
  • Publication number: 20140130209
    Abstract: This disclosure relates generally to the field of anti-pathogenic agents, including a modified defensin molecule with anti-pathogen activity. Genetically modified plants and their progeny or parts expressing or containing the modified defensin and anti-pathogen compositions for use in horticulture and agriculture and as animal and human medicaments are also provided.
    Type: Application
    Filed: February 7, 2012
    Publication date: May 8, 2014
    Applicant: HEXIMA LIMITED
    Inventors: Nicole Van Der Weerden, Marily Anne Anderson
  • Publication number: 20090197809
    Abstract: A system for reducing the incidence or severity of fungal infection of a plant, comprising a chemical fungicide component, which may be provided by foliar or root (soil or liquid nutrient) application, together with an antifungal plant defensin not in nature expressed in the plant being protected or expressed in lower amounts or in different tissues, provides synergistic improvement in protection against infection by a plant pathogenic fungus which is susceptible to the defensin and the fungicide. The fungicide can be a strobilurin or a triazole, and the defensin can be selected from a wide range of known defensins, for example, NaD1 and others, or it can be a chimeric defensin engineered for low toxicity to the plant. The defensin can be provided as a protein formulation, optionally together with the fungicide, or it can be provided by recombinant expression in the plant to be protected from fungal infection.
    Type: Application
    Filed: January 30, 2009
    Publication date: August 6, 2009
    Applicant: Hexima Limited
    Inventors: Marilyn Anderson, Robyn Heath, James McKenna, Nicole van der Weerden